Loading clinical trials...

Reducing Clinical Inertia in Hypertension Treatment: A Pragmatic Trial | Clinical Trials | Clareo Health

COMPLETEDNA

Reducing Clinical Inertia in Hypertension Treatment: A Pragmatic Trial

Health Promotion Outreach To Overcome Clinical Inertia In The Treatment Of Patients With Poorly-Controlled Hypertension

NCT01145391•University of Colorado, Denver

Summary

The goal of this project is to use health information technology and team-based care in novel ways to support the establishment of a Patient-Centered Medical Home model of care aimed at improving the diagnosis and management of hypertension. Compared with patients who receive usual care, patients who receive intervention will have a lower average systolic blood pressure 9 months after randomization.

Eligibility

Age

18 - 79 years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Adult men and women age 18-79
•At least 2 Blood Pressure readings from separate days on record
•Average of last 3 Blood Pressure readings (or last 2 if only 2 available) with (Systolic Blood Pressure ≥140 or Diastolic Blood Pressure ≥90) and (last Systolic Blood Pressure ≥135 or last Diastolic Blood Pressure ≥85), recorded by any University of Colorado Hospital clinic within the last 18 months
•No clinic visit in the past month
•At least one Primary Care Physician visit in the past 18 months
•First Primary Care Physician visit at least 6 months in the past

Exclusion Criteria

•Serious comorbidities, including active cancer diagnosis, hospice care, nursing home residence
•Diagnosis of diabetes (these patients are enrolled in a separate study that also targets Blood Pressure control)
•End-stage renal disease / hemodialysis
•Primary Care Physician appointment pending
•Patient instructed to monitor Blood Pressure at home / documentation of white coat hypertension
•Blood Pressure managed by specialist or outside provider

Locations (1)

University of Colorado Denver

Aurora, Colorado, United States

Key Dates

Start Date

November 1, 2009

Primary Completion Date

October 1, 2010

Completion Date

October 1, 2010

Last Updated

August 15, 2018

Enrollment

591

ACTUAL participants

Conditions

Hypertension

Interventions

Active Outreach to Patients and Providers

OTHER

Natural History of Noncirrhotic Portal Hypertension

NCT02417740

Cystic FibrosisImmunologic Deficiency Syndrome+3 more

View study

RECRUITING

Homocysteine and Early Diastolic Dysfunction in Newly Diagnosed Hypertension

NCT07480265

Hypertension (HTN)Hyperhomocysteinemia+1 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 15, 2018Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Reducing Clinical Inertia in Hypertension Treatment: A Pragmatic Trial

Inclusion Criteria

Exclusion Criteria

Natural History of Noncirrhotic Portal Hypertension

Homocysteine and Early Diastolic Dysfunction in Newly Diagnosed Hypertension

A Study to Learn About the Study Medicine (Called PF-07868489) in People With Pulmonary Arterial Hypertension Who Have Previously Participated in a Clinical Study With PF-07868489

Mobile Cued Adherence Therapy (mCAT) for Blood Pressure Medication

Penn Medicine Healthy Heart

Preliminary Human Trials of F230 Tablets